Edal, Baby Boy .
HRN: 24-67-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/25/2024
04/01/2024
IV
52 Mg LD Then 26mg Maintenance
Q 8 Hours
Meconium Aspiration Syndrome
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes